SCHEMBL4496717

SCHEMBL4496717

Cc1cc(C)nc(NC(=O)c2cc(COc3cc(F)ccc3Cl)ccn2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.60
KDM4E B2RXH2 2/20 0.60
MEN1 O00255 1/20 0.60
PKM P14618 1/20 0.60
KMT2A Q03164 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 2/20 0.44
GRM5 P41594 2/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.42
ADORA1 P30542 1/20 0.42
ANO1 Q5XXA6 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SCD O00767 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501168 0.92 MAPT (0.60) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4507587 0.90 SMN1; SMN2 (0.59) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4500386 0.89 MAPT (0.74) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4502419 0.86 MAPT (0.59) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4513766 0.83 MAPT (0.48) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4492876 0.78 MAPT (0.52) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4509663 0.78 MRGPRX4 (0.62) MEN1KMT2ASMN1; SMN2MRGPRX4KDM5A
SCHEMBL4508993 0.76 MRGPRX4 (0.47) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4500960 0.74 SMN1; SMN2 (0.58) MAPTKDM4EMEN1PKMKMT2A
SCHEMBL4492672 0.73 ALDH1A1 (0.53) MAPTKDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS MAPT 4022/4885KDM4E 249/4885MEN1 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.